Target intelligence / Profile preview

ASNS pseudogene 1 (ASNSP1)

Target
ASNSP1
Molecular classification
Other (Pseudogene)
01

Overview

ASNS pseudogene 1 (ASNSP1) is a pseudogene, meaning it is a genomic DNA sequence similar to the protein-coding ASNS gene but is typically not translated into a functional protein. The ASNS gene encodes asparagine synthetase, an enzyme critical for asparagine biosynthesis[1][3][5]; however, pseudogenes like ASNSP1 generally lack functional protein expression due to mutations or truncations. In general, pseudogenes can sometimes influence cellular function by serving as sources for regulatory RNAs or by acting as molecular decoys in RNA networks (ceRNA), but there is currently no published evidence that ASNSP1 has such a role[2]. ASNSP1 is not considered a therapeutic target because it does not produce an active enzyme or receptor, and there are no drugs directly interacting with it. Furthermore, listing it as a therapeutic target is incorrect unless future evidence establishes such a function. If your intention was the actual asparagine synthetase gene (ASNS), that is a protein-coding enzyme, but "ASNSP1" itself is a pseudogene and not a drug target[1][3][5].

Other names
asparagine synthetase pseudogene 1
02

Biological functions

Regulatory (potential RNA-level regulation through ceRNA/miRNA mechanisms in theory, but not proven for ASNSP1 specifically)
03

Disease associations

Other (No established direct disease role; pseudogenes may sometimes affect disease through gene regulation, but this has not been demonstrated for ASNSP1 specifically)

Beyond the preview

Go deeper on ASNS pseudogene 1 (ASNSP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASNS pseudogene 1 (ASNSP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call